@article{JGO1154,
author = {Walid Shaib and Reena Mahajan and Bassel El-Rayes},
title = {Markers of resistance to anti-EGFR therapy in colorectal cancer},
journal = {Journal of Gastrointestinal Oncology},
volume = {4},
number = {3},
year = {2013},
keywords = {},
abstract = {Epidermal growth factor receptor (EGFR) is a therapeutic target in colorectal cancer (CRC). The benefit from EGFR inhibitors appears to be limited to a subset of patients with CRC. Mechanisms of resistance to EGFR inhibitors are being identified. KRAS codon 12 activating mutation is a predominate mechanism of resistance to EGFR inhibitors in around 40% of patients with advanced CRC. Other potential mechanisms of resistance include ligand expression, increased EGFR number, mutations of BRAF and activation of alternate signaling pathways.},
issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/1154}
}